Trials / Completed
CompletedNCT00257920
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
A Phase 4, Single-Center, Open-Label, Randomized, Active-Controlled, Cross-over Pilot Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in CKD Stage 5 Subjects on Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zemplar® injection | 6 mcg QOD |
| DRUG | Hectorol® injection | 3.6 mcg QOD |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2008-01-01
- First posted
- 2005-11-24
- Last updated
- 2009-12-24
- Results posted
- 2009-05-20
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00257920. Inclusion in this directory is not an endorsement.